Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Industry Fears 'Double Taxation' For Combo Products, Device Kits

This article was originally published in The Pink Sheet Daily

Executive Summary

IRS is developing guidance to implement a 2.3% device tax created by the health care reform law and set to go into effect on Jan. 1, 2013. But companies selling drug-device combination products are concerned that they could be liable for both the device tax and a prescription drug manufacturer fee also established in the 2010 reforms.

You may also be interested in...



Debate Over Device Tax Guidance Divides Hospitals, MedTech Groups

Hospitals and group purchasers are pressing the Internal Revenue Service to develop regulations that would make it more difficult for medical technology firms to pass the costs of the upcoming device excise tax onto customers.

AdvaMed Seeks Broad Exemptions From Medical Device Excise Tax

The Internal Revenue Service should be flexible in deciding which medical devices will be exempt from a new excise tax, AdvaMed says.

Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind

Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.

Topics

UsernamePublicRestriction

Register

PS142351

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel